• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

A prospective study on effect of controlled hba1c levels and normotension in the development of diabetic retinopathy in type 2 diabetics

    Dr. Chaithra CM, Dr. Kshama K

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 1410-1416

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: To determine the importance of HbA1C levels and normotension in predicting the development of diabetic retinopathy and the relationship between them.
Method: Prospective clinical study comprising of a group of 125 diabetics above 40 years visiting for routine eye checkup and clinically diagnosed diabetic retinopathy including both out-patient and in-patients at Department of Ophthalmology, KIMS, Bangalore. Men and women >40years with type 2 diabetes mellitus with HbA1C levels <7.5% and non-hypertensives (<140mmHg systolic and <90mmHg diastolic pressure) were included. Patient’s HbA1C levels and blood pressure were measured. The diabetic retinopathy status was classified according to the ETDRS system. Statistical analysis was done.
Results: At 3rd month follow up, the mean HbA1C levels was 7.25±0.22.At the end of 12th month, the mean HbA1C was 7.42±0.11At baseline, in group A 8.8% showed mild NPDR and 1.6% moderate NPDR. At the end of the study it was 8.8% mild NPDR, 1.6% moderate NPDR. No further progression was seen in a year span. All values showed statistical significance and absence of hypertension also goes in favour of mild diabetic retinopathy changes.
Conclusion: HbA1C levels and systemic hypertension are the two major modifiable risk factors in the development and progression of diabetic retinopathy
Keywords:
    HbA1c Hypertension Diabetic Retinopathy
  • PDF (551 K)
  • XML
(2022). A prospective study on effect of controlled hba1c levels and normotension in the development of diabetic retinopathy in type 2 diabetics. European Journal of Molecular & Clinical Medicine, 9(2), 1410-1416.
Dr. Chaithra CM, Dr. Kshama K. "A prospective study on effect of controlled hba1c levels and normotension in the development of diabetic retinopathy in type 2 diabetics". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 1410-1416.
(2022). 'A prospective study on effect of controlled hba1c levels and normotension in the development of diabetic retinopathy in type 2 diabetics', European Journal of Molecular & Clinical Medicine, 9(2), pp. 1410-1416.
A prospective study on effect of controlled hba1c levels and normotension in the development of diabetic retinopathy in type 2 diabetics. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 1410-1416.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 54
  • PDF Download: 92
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus